Trial
NCT04327934
Mechanisms of Hypertension in Women With Polycystic Ovary Syndrome
Early Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Yale University
Collaborators
National Heart, Lung, and Blood Institute (NHLBI)
Condition
Polycystic Ovary Syndrome
Intervention
GnRH antagonist
Why stopped
Unble to complete all arms of the planned study due to Covid stoppage and difficulty with recruiting and getting enrolled participants to return post Covid.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-02-02